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Abstract
Background: Although an adverse early-life environment has been linked to an increased risk of developing the
metabolic syndrome, the molecular mechanisms underlying altered disease susceptibility as well as their relevance
to humans are largely unknown. Importantly, emerging evidence suggests that these effects operate within the
normal range of birth weights and involve mechanisms of developmental palsticity rather than pathology.
Method: To explore this further, we utilised a non-human primate model Macaca fascicularis (Cynomolgus
macaque) which shares with humans the same progressive history of the metabolic syndrome. Using microarray
we compared tissues from neonates in the average birth weight (50-75th centile) to those of lower birth weight (5-
25th centile) and studied the effect of different growth trajectories within the normal range on gene expression
levels in the umbilical cord, neonatal liver and skeletal muscle.
Results: We identified 1973 genes which were differentially expressed in the three tissue types between average
and low birth weight animals (P < 0.05). Gene ontology analysis identified that these genes were involved in
metabolic processes including cellular lipid metabolism, cellular biosynthesis, cellular macromolecule synthesis,
cellular nitrogen metabolism, cellular carbohydrate metabolism, cellular catabolism, nucleotide and nucleic acid
metabolism, regulation of molecular functions, biological adhesion and development.
Conclusion: These differences in gene expression levels between animals in the upper and lower percentiles of
the normal birth weight range may point towards early life metabolic adaptations that in later life result in
differences in disease risk.
Background
Clinical, experimental and epidemiological studies have
highlighted a link between the early-life environment
and the health and well-being of offspring in later life.
An adverse maternal environment has been linked to an
increased risk of developing metabolic and cardiovascu-
lar disorders including type 2 diabetes, obesity, hyperli-
pidemia, insulin resistance and hypertension [1-7]. An
important feature of these studies is that these relation-
ships exist within the normative birth range and do not
depend on extremes of birth weight. This has led to the
proposal that later life disease risk is the result of mala-
daptive consequences of plastic mechanisms which
would normally be adaptive [8,9].
It is proposed that developmental plasticity determines
the trajectory of development through epigenetic pro-
cesses such that the fetus attempts to match its later
phenotype to the environment [10]. It has been pro-
posed that low birth weight is a marker of a poor early
life nutritional environment [11] and thus a smaller
fetus is more likely to develop a metabolic capacity
appropriate for a low nutrient postnatal environment.
But, if faced with a high nutrient environment it is more
likely to become obese and insulin resistant [12].
Although, epigenetic processes have been increasingly
implicated largely from rodent studies involving
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nutritional manipulation of the dam [13,14] the molecu-
lar mechanisms underlying altered disease susceptibility
are largely unknown. There is also some evidence that
these developmental trajectories, and associated long-
term gene expression and epigenetic changes can be
reversed by the administration of the adipokine leptin to
the neonatal rat although the concentrations used were
higher than physiological levels [10,12,15,16]. These data
suggest that a better understanding of the molecular
events associated with impaired early life development
may help in designing future intervention strategies.
To identify the possible molecular pathways associated
with variations in the fetal environment, we have utilised
a non-human primate (NHP) model, the Macaca fasci-
cularis (Cynomolgus macaque) to elucidate whether var-
iations within the normal birth weight range are
associated with differential gene expressions patterns.
Cynomolgus macaques share with humans the same
progressive history of the metabolic syndrome [17]
which makes this model directly relevant to humans
and importantly, Cynomolgus macaque is a monotocous
species in which spontaneous variation in fetal growth
rather than experimental manipulation can be investi-
gated. This study therefore we have investigated the
effect of spontaneous lower birth weight on gene
expression in key tissues (umbilical cord, hepatic tissue
and skeletal muscle) from female Cynomolgus macaque
neonates.
Methods
Collection of Umblical cords
Sixty-five pregnant Cynomolgus macaque dams, sired
naturally by one male, were monitored prior to delivery
at the Vietnam Primate Breeding and Development Cor-
poration. After birth, dams were sedated (ketamine-HCl;
7 mg/kg) to facilitate collection of the umbilical cord.
The cords were collected and immediately snap-frozen
in liquid nitrogen and stored at -80°C for later analyses.
Neonates were weighed at birth and promptly returned
to the dams. All animal procedures were approved by
Nafovanny, subsidiary of the Ministry of Forestry, Viet-
nam, and performed in accordance with the guidelines
set by the national advisory committee for laboratory
animal research (NACLAR) of Singapore.
Collection of hepatic and skeletal muscle samples
The normative birth range was assessed from these 65
pregnancies and 8 neonates were selected based on their
birth weights to comprise 2 groups: 1) lower birth
weight group (LBW); n = 4 classified as those that were
within the 5th to 25th birth weight percentile, birth
weight range 299-317 g and 2) average birth weight
group (ABW); n = 4 classified as those that were within
the 50th to 75th birth weight percentile, birth weight
range 358-398 g. The normal gestation of Cynomolgus
macaque is approximately 155-170 days [18]. We have
estimated the gestational age based on early ultrasound
measurements (greatest length of the embryo at the
time of pregnancy detection) and used those pregnan-
cies where fetuses were within normal distribution for
full term Cynomolgus macaques [18]. On postnatal day
5, neonates were sedated with an intramuscular injec-
tion of ketamine-HCl (15 mg/kg), and exsanguinated
under anesthesia. Liver and skeletal muscle (biceps
femoris) were collected and immediately snap frozen in
liquid nitrogen and stored at -80°C for later analyses
Preparation of Total RNA
Total RNA was isolated from umbilical cords and neo-
natal tissues using TRIzol reagent according to the man-
ufacturer’s instructions (Invitrogen). RNA integrity was
confirmed by bio analyzer 2100 (Agilent Technologies,
Santa Clara, USA). An RNA Integrity Number (RIN)
value of 7.5 above was considered acceptable and used
in further experiments.
Microarray analysis
For microarray analysis, RNA from 6 groups of samples
(Cord: ABW and LBW; Liver: ABW and LBW; skeletal
muscle: ABW and LBW) were labeled using QuickAmp
1-color labeling kit (Agilent Technologies) according to
manufacturer’s protocol. The Cy3 labeled cRNA were
subsequently hybridized to Agilent Rhesus Macaque
(G2519F-015421) Gene Expression microarray. The
Rhesus macaque gene expression microarray used in
this study represented 43,803 Rhesus monkey probes
synthesized as 60-mers spotted using the Agilent Sure-
Print technology (Agilent Technologies). The microar-
rays were scanned with Agilent High resolution Scanner
and the images were feature extracted using FE software
version 10.5 (Agilent Technologies).
Data analysis was performed using Genespring GX
ver10 (Agilent Technologies). The raw signal intensity
from each samples is global normalized to 75th percen-
tile and base-line transformed. Probes flagged with pre-
sent call in at least 75% of the samples in any of the 6
groups were used for subsequent data analysis.
Two-way ANOVA was performed with p value cut-off
at 0.05 to identify genes that are differentially expressed
in the tissue type and birth weight. Due to limited anno-
tation of Rhesus Monkey genome, the microarray probes
are annotated against human genes and ontology. For
mapping against the human genome, the probes from
the monkey microarray were re-annotated using Agilent
eARRAY. The probe sequences were aligned to human
genome (hg18) using BLAST based algorithm and the
associated human annotation was extracted from the
database.
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To study the gene expression profile of the birth
weight in each of the tissue type, Welch T-Test with p-
value cut off of 0.05 and fold change of 1.5X was per-
formed between the ABW and LBW samples in each of
the tissue groups.
Complete microarray data is available at the Gene
Expression Omnibus (GEO) database under the acces-
sion number GSE32069.
Network Analysis
The microarray data was imported into Pathway Studio
version 7 (Ariadne Genomics, Rockville, USA) for net-
work analysis. Gene Set Enrichment Analysis (GSEA)
was performed on ABW vs LBW in the respective tissue
using Kolmogorov-Smirnov algorithm with p-value cut-
off at 0.05. In addition, Network Enrichment Analysis
(NEA) was performed to identify expression hub of the
treatment. Sub network was generated by connecting
entities to their expression target network using the
Resnet 7 Mammalian database.
Quantitative RT-PCR
Five up-regulated and two down regulated genes were
selected for verification using qRT-PCR. The primers
were designed using the Cynomolgus if available or Rhe-
sus macaque sequences using the primer 3 software if
not available [19]. The gene symbols and the primers
are listed in Table 1.
We used skeletal muscle RNA to verify the array.
Briefly, total RNA was extracted as mentioned above
from four ABW and four LBW neonates and were
reverse transcribed using Applied Biosystem’s high-capa-
city cDNA reverse transcription kit using 1 μg of total
RNA in a reaction volume of 20 μl. The PCR reactions
were carried out in 25 μl of SYBR Green Master Mix
with 200 ng of cDNA using 7500 real time PCR system
(Applied Biosystems, CA, USA). The comparative Ct
method was used to calculate the relative gene expres-
sion [20]. 18S RNA was used as the internal control
which was validated using the method described in




Two-way factorial ANOVA identified 1973 genes which
were differentially expressed in the three tissue types
between ABW and LBW neonates (P < 0.05). Of these,
1141 genes were up regulated in the LBW samples
while 832 genes were down-regulated in the LBW sam-
ples compared to ABW (Figure 1).
Gene expression profiles of umbilical cord, liver and
skeletal muscle were also compared using Welch-t-test.
There were 250 genes significantly and differently
expressed in the liver, 850 genes significantly and differ-
ently expressed in the skeletal muscle and 891 genes sig-
nificantly and differently expressed in cord samples (P <
0.05, >1.5 fold difference) (Figure 2, 3). The top 50
genes whose gene expression levels changed in each tis-
sue based on their fold difference based on Welch T-
test are given in Tables 2, 3, 4.
Of the 250 genes which were differently expressed in
the liver, 182 genes were unique to the liver (115 genes
up regulated in the LBW group and 67 genes down-
regulated in the LBW group). There were 19 genes
which were significantly and differently expressed
between liver and skeletal muscle (16 up regulated in
LBW skeletal muscle and 15 genes up regulated in liver
and 3 down-regulated in the LBW skeletal muscle and 4
down regulated in LBW liver). There were 5 genes
which are significantly and differently expressed between
liver and cord (3 up regulated in LBW liver and 2 genes
up regulated in LBW cord and 2 down regulated in
LBW liver and 3 down regulated in the cord).
Of the 850 genes significantly and differently
expressed in skeletal muscle, 733 genes were specific to
the skeletal muscle; i.e. showed altered regulation only
in the skeletal muscle (584 genes up regulated in the
LBW samples and 149 genes down regulated in the
LBW group). There were 94 genes which were
Table 1 Sequences of primers used for qRT-PCR:
PASK F 5’ CTACTCCGGGAGCTGCTATC 3’
PASK R5’ AGCAGCAGAACAGAGGTGTG 3’
116936 F5’ GCACATCTGCCTGAAGTGAA 3’
116936 R5’ GAGCAGCTTGTCCAGGAAGT 3’
ADK F5’ TGGTGGCTCTACCCAGAACT 3’
ADK R5’ CATCTACATGGGCTTCAGCA 3’
ELMO F5’ AGCTCTGTGTGGCTTGGTTT 3’
ELMO R5’ CGGTGTGAATAACGGAGTCCT 3’
SIX1 F5’ GTTTAAGAACCGGAGGCAAA 3’
SIX1 R5’ GGAGAGAGTTGGTTCTGCTTG 3’
SLC12A9 F5’ GGCTTCAACAGCAGTACCCT 3’
SLC12A9 R5’ AAGAGGACAGCAAAGACGCT 3’
RBL1 F5’ TAGCCTGACCAACATGGAGA 3’
RBL1 R5’ GTTCAAGCAATTCTGCCTCA 3’
Uni18SrRNA F5’ AGTCCCTGCCCTTTGTACACA 3’
Uni18SrRNA R5’ GATCCGAGGGCCTCACTAAAC 3’
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Figure 1 Hierarchical clustergram of 1973 genes (1141 up
regulated in LBW and 832 down regulated in LBW) identified
by ANOVA (P < 0.05) in all the three tissues (umbilical cord (C),
liver (L) and skeletal muscle (B) analyzed. The relative expression
is reflected by the intensity of the color (Green = down regulated,
red = up regulated)
Figure 2 Heat map depicting the differentially expressed
genes in skeletal muscle (850 genes), liver (210 genes) and
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significantly and differently expressed between skeletal
muscle and cord (60 up regulated in LBW skeletal mus-
cle and 22 genes up regulated in LBW cord and 34
genes down regulated in the LBW skeletal muscle and
72 genes down regulated in the LBW cord).
Of the 891 genes significantly and differently
expressed in umbilical cord; 788 genes showed altered
regulation only in umbilical cord (338 genes up regu-
lated and 450 genes down regulated in LBW group).
There were 4 genes which are significantly and differ-
ently expressed between liver, skeletal muscle and umbi-
lical cord (4 genes up regulated in the LBW skeletal
muscle and liver while the same four genes were down
regulated in LBW cord) Figure 2, 3.
Functional classification of genes
Gene ontology was used to classify genes based on func-
tional significance. The main component of the Gene
Ontology (GO) annotation taken into consideration was
metabolic function. Genes were classified into fifteen
functional categories: Cellular lipid metabolic process
(43 genes), Cellular biosynthetic process (95 genes), Cel-
lular macromolecule synthesis (222 genes), Cellular
nitrogen compound metabolic process (10 genes), Cellu-
lar carbohydrate metabolic process (6 genes), Cellular
catabolic process (9 genes), Nucelobase, Nucleoside,
nucleotide and nucleic acid metabolic process (216
genes), Other cellular metabolic process (29 genes),
Other metabolic process (36 genes), Transport (141
genes), Regulation of molecular functions (28 genes),
Biological adhesion (27 genes), Developmental process
(74 genes) Other biological processes (252 genes) and
Non classified (795) with p-value of (p > 0.05). The
genes enriched for each GO term were further classified
into the number of genes up regulated or down regu-
lated in each tissue with a fold difference of 1.5 or
greater (Table 5) (Additional file 1).
Quantitative RT-PCR
To validate the micoarray results we carried out quanti-
tative RT-PCR (qRT-PCR) using the same RNA samples
in the microarray analysis. We selected seven genes (a
novel gene XM_116936, PAS domain containing serine/
threonine kinase (PASK), Adenisine kinase (ADK) tran-
script variant ADK-short, ELMO/CED-12 domain con-
taining 1 (ELMOD1), Sine oculins homeobox homolog 1
(SIX1) Retinoblastoma like-1 (RBL1) and Solute carrier
family 12 (potassium/chloride transporters) member 9
(SLC12A9) for this validation of the array using skeletal
muscle cDNA. Of these 5 genes were significantly up
regulated in the array and 2 genes were significantly
down regulated in the array. Our results from the qPCR
complement our results from the microarray (Table 6).
The fold differences along with the values which derived
from the microarray are presented in Table 6.
Discussion
In the present study, we have identified genes involved
in key metabolic signaling pathways in three tissue types
in a non-human primate model, that were differentially
expressed according to the birth weight of the animal.
Importantly, this differential expression was across the
normal birth weight spectrum and therefore likely to
represent adaptive pathways that the fetuses uses to pre-
dict its postnatal environment. The identification of
novel signaling pathways that appear to be regulated by
the early life environment is a key step in designing
future experimental paradigms to understand the asso-
ciation between birth weight and disease risk. Metabolic
Figure 3 Venn diagram depicting the differentially expressed
genes in skeletal muscle (850 genes), liver (210 genes) and
cord (891 genes) t-test unpaired unequal variance, LBW vs
ABW, p < 0.05, >= 1.5 fold difference.
cord (891 genes) (P < 0.05, >= 1.5 fold difference). A. 733 genes
(584 genes up regulated in LBW skeletal muscle, 149 genes down
regulated in LBW skeletal muscle), B. 19 genes (16 genes up
regulated in LBW skeletal muscle and 15 genes up regulated in LBW
liver, 3 genes down regulated in LBW skeletal muscle and 4 genes
down regulated in liver). C 182 genes (115 genes up regulated in
LBW liver and 67 genes down regulated in LBW liver). D 5 genes (2
genes up regulated in LBW cords and 3 genes up regulated LBW
liver, 3 genes down regulated in LBW cords and 2 genes down
regulated in LBW liver). E. 788 genes (338 genes up regulated in
LBW cord and 450 genes down regulated LBW cord). F. 94 genes
(60 genes up regulated in LBW skeletal muscle and 22 up regulated
in LBW cord, 34 genes down regulated in LBW skeletal muscle and
72 genes down regulated in LBW cord. G. 4 genes (4 genes up
regulated in LBW skeletal muscle and liver, 4 genes down regulated
in LBW cord).
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XM_116936 0.017913306 10.054285 up 1.080386 up 2.185324 up PREDICTED: Homo sapiens similar to
RIKEN cDNA 4832428D23 gene
(LOC196541) mRNA [XM_116936]
XM_056254 0.021895792 9.569201 up 2.09208 down 1.391897 up PREDICTED: Homo sapiens heparan
sulfate (glucosamine) 3-O-
sulfotransferase 4 (HS3ST4) mRNA
[XM_056254]
C5orf23 0.01475329 6.0808635 up 1.072585 up 1.301361 up Homo sapiens chromosome 5 open
reading frame 23 (C5orf23), mRNA
[NM_024563]
PASK 0.03426426 5.977056 up 2.995584 up 19.17474 up Homo sapiens PAS domain
containing serine/threonine kinase
(PASK), mRNA [NM_015148]
WDR8 0.004681234 5.6804295 down 2.978104 down 8.061375 down Homo sapiens WD repeat domain 8
(WDR8), mRNA [NM_017818]
ADK 1.63E-04 5.639505 down 1.368648 down 9.386349 down Homo sapiens adenosine kinase
(ADK), transcript variant ADK-short,
mRNA [NM_001123]
APOBEC3G 0.040698703 4.8567457 down 1.669566 down 1.105857 down Homo sapiens apolipoprotein B
mRNA editing enzyme, catalytic
polypeptide-like 3G (APOBEC3G),
mRNA [NM_021822]
CCL2 0.002121243 4.757898 down 1.287543 down 2.895307 down Homo sapiens chemokine (C-C motif)
ligand 2 (CCL2), mRNA [NM_002982]
A_01_P013390 0.029869065 4.6248507 down 1.099004 down 1.527467 down
BC044226 0.04677891 4.3998837 down 1.966762 down 1.502299 down Homo sapiens myosin binding
protein H, mRNA [BC044226]
CCL11 0.008992519 4.050988 down 3.178148 down 1.002582 up Homo sapiens chemokine (C-C motif)
ligand 11 (CCL11), mRNA
[NM_002986]
POU4F3 0.02459994 3.8642302 up 1.615214 up 1.991698 down Homo sapiens POU domain, class 4,
transcription factor 3 (POU4F3),
mRNA [NM_002700]
XR_011794 0.010519872 3.7855186 up 3.637105 up 2.76764 up PREDICTED: Macaca mulatta similar to
poly(A)-specific ribonuclease (PARN)-
like domain containing 1
(LOC707835), mRNA [XR_011794]
H1FOO 0.011109326 3.7804163 up 1.404401 up 1.449255 down Homo sapiens H1 histone family,
member O, oocyte-specific (H1FOO),
mRNA [NM_153833]
C17orf75 0.001362531 3.7583363 down 3.447702 down 1.443745 down Homo sapiens chromosome 17 open
reading frame 75 (C17orf75), mRNA
[NM_022344]
RNF216 0.001650785 3.7307158 down 1.504036 down 6.793567 down Homo sapiens TRIAD3 protein
(TRIAD3), transcript variant 1, mRNA
[NM_207111]
GTSF1 0.017040279 3.6632807 up 4.653995 up 2.487166 up Homo sapiens family with sequence
similarity 112, member B (FAM112B),
mRNA [NM_144594]
C13orf33 0.006214988 3.5870998 down 2.664488 down 1.061963 up Homo sapiens chromosome 13 open
reading frame 33 (C13orf33), mRNA
[NM_032849]
CA2 0.033340864 3.5736616 down 3.483002 down 1.194329 up Homo sapiens carbonic anhydrase II
(CA2), mRNA [NM_000067]
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Table 2 List of top 50 genes significantly differentially regulated in the skeletal muscle based on fold difference
(t-test) (Continued)
CO645773 0.03704907 3.5384166 down 2.022003 down 1.474969 down ILLUMIGEN_MCQ_30118 Katze_MMPB
Macaca mulatta cDNA clone
IBIUW:22572 5’ similar to Bases 1 to
42 highly similar to human RARRES3
(Hs.17466), mRNA sequence
[CO645773]
MYST3 0.013409907 3.3029778 up 2.827006 up 1.403819 up Homo sapiens MYST histone
acetyltransferase (monocytic
leukemia) 3 (MYST3), mRNA
[NM_006766]
NM_000977 0.008561992 3.2655115 up 2.138359 up 2.014805 up Homo sapiens ribosomal protein L13
(RPL13), transcript variant 1, mRNA.
[NM_000977]
XR_014265 0.001382546 3.2319098 down 1.270026 down 2.168579 down PREDICTED: Macaca mulatta
hypothetical protein LOC716045
(LOC716045), mRNA [XR_014265]
NM_001004685 0.043442905 3.1747854 up 1.353824 up 1.407273 down Homo sapiens olfactory receptor,
family 2, subfamily F, member 2
(OR2F2), mRNA. [NM_001004685]
XR_014204 0.029225934 3.167453 down 3.849135 down 1.084816 up PREDICTED: Macaca mulatta
hypothetical protein LOC719546
(LOC719546), mRNA [XR_014204]
DARS 3.99E-05 3.1527941 down 1.10567 down 12.63266 down Homo sapiens aspartyl-tRNA
synthetase (DARS), mRNA
[NM_001349]
GYLTL1B 9.45E-04 3.143812 up 1.169517 up 3.19979 up Homo sapiens glycosyltransferase-like
1B (GYLTL1B), mRNA [NM_152312]
CNNM2 1.94E-04 3.1423542 up 1.00608 down 1.785853 up Homo sapiens cyclin M2 (CNNM2),
transcript variant 1, mRNA
[NM_017649]
C20orf26 0.023210809 3.1168563 up 1.353857 up 1.414684 up Homo sapiens chromosome 20 open
reading frame 26 (C20orf26), mRNA
[NM_015585]
SLC26A9 0.042099766 3.0884879 up 2.137558 up 1.776504 up Homo sapiens solute carrier family
26, member 9 (SLC26A9), transcript
variant 1, mRNA [NM_052934]
SEC14L3 0.025527291 3.0402198 up 1.787294 up 1.547541 down Homo sapiens SEC14-like 3 (S.
cerevisiae) (SEC14L3), mRNA
[NM_174975]
TMEM20 0.001055841 2.9346027 down 1.821723 down 1.558415 down Homo sapiens transmembrane
protein 20 (TMEM20), mRNA
[NM_153226]
UHRF1 0.042854026 2.9323897 down 1.272487 down 1.455897 down Homo sapiens ubiquitin-like,
containing PHD and RING finger
domains, 1 (UHRF1), transcript variant
2, mRNA [NM_013282]
CST9L 0.008572864 2.9286344 up 1.46455 up 1.695363 down Homo sapiens cystatin 9-like (mouse)
(CST9L), mRNA [NM_080610]
C2 0.005425731 2.906241 down 1.470166 down 1.228973 up Homo sapiens complement
component 2 (C2), mRNA
[NM_000063]
C7orf62 0.03373279 2.8281868 up 1.466387 up 1.326441 down Homo sapiens hypothetical protein
MGC26647 (MGC26647), mRNA
[NM_152706]
HOXB13 0.008404698 2.822795 up 1.530259 up 1.061908 down Homo sapiens homeobox B13
(HOXB13), mRNA [NM_006361]
ANLN 0.026928915 2.8110342 down 1.205709 down 1.210447 down Homo sapiens anillin, actin binding
protein (ANLN), mRNA [NM_018685]
TMEM45B 0.02836952 2.789488 up 1.108079 up 1.434473 up Homo sapiens transmembrane
protein 45B (TMEM45B), mRNA
[NM_138788]
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disease particularly, has been strongly with early life
adversity [21,22]. Our data begin to shed light on the
key signaling pathways that are vulnerable to subtle
changes in the early life environment.
The strength of our study, despite its small size, is that
we have focused on infants whose growth was not
experimentally manipulated but lay within normal birth
weight range. Many experimental models have manipu-
lated pregnancy in an effort to produce fetal growth
restriction. Such studies have shown that offspring
which are born growth restricted catch-up in growth
with their normally nourished counterparts and in
adulthood are obese, hypertensive, hyperinsulinemic,
leptin resistant and display sedentary behavior [23-25].
Investigations into underlying mechanisms and the
determination of gene expression levels that may explain
these altered phenotypes have produced conflicting
results [26-28] which may reflect variations in the
model systems used and the gender of the animals used
[28]. Taken together, although these studies have estab-
lished the link between early life nutritional adversity to
later pathophysiology, there are limitations in the inter-
pretation of rodent studies in development as applied to
humans.
In the present study we aimed to study the molecular
associates of growth variation within the normative
range and exclude pathology. This is because the grow-
ing literature on developmental outcomes highlights
that the importance of variation in risk is associated
with non-pathological developmental environments.
Accordingly we studied relatively small infants born
between the 5th and 25th centile but excluded the smal-
lest neonates, which may reflect obstetrical abnormal-
ities. These infants were compared to infants in the
middle of the normative range (50th-75th centile) and
accordingly we excluded infants who may have had
macrosomia as a result of the mother’s being over-nour-
ished by being maintained in captivity. Thus we are con-
fident that we have excluded pathological influences and
demonstrated that within the normative range patterns
of gene expression may vary considerably with variable
birth weights. Indeed we found a number of genes with
Table 2 List of top 50 genes significantly differentially regulated in the skeletal muscle based on fold difference
(t-test) (Continued)
COL8A2 0.029133584 2.7760508 down 1.111961 down 2.334076 down Homo sapiens collagen, type VIII,
alpha 2 (COL8A2), mRNA
[NM_005202]
IL15RA 3.56E-05 2.7710447 down 2.542192 down 5.776398 down Homo sapiens interleukin 15
receptor, alpha (IL15RA), transcript
variant 2, mRNA [NM_172200]
AY937248 0.002621024 2.7557867 up 1.074139 down 2.046131 up Macaca mulatta placental protein 14
mRNA, complete cds [AY937248]
SCN3B 0.00199475 2.7342772 up 1.566765 up 1.26591 up Homo sapiens sodium channel,
voltage-gated, type III, beta (SCN3B),
transcript variant 1, mRNA
[NM_018400]
TRIM6 0.005424626 2.7181938 up 1.451755 up 1.960095 up Homo sapiens tripartite motif-
containing 6 (TRIM6), transcript
variant 1, mRNA [NM_001003818]
TNS4 0.041628703 2.7158492 up 1.315606 up 1.297834 down Homo sapiens tensin 4 (TNS4), mRNA
[NM_032865]
PDE1C 0.026903268 2.6685586 up 1.596604 up 1.15087 down Homo sapiens phosphodiesterase 1C,
calmodulin-dependent 70kDa
(PDE1C), mRNA [NM_005020]
S100A4 0.01836204 2.656307 down 1.047433 down 2.01034 down Homo sapiens S100 calcium binding
protein A4 (S100A4), transcript variant
1, mRNA [NM_002961]
AADACL1 0.017924123 2.6216743 down 1.119603 down 1.47176 down Homo sapiens arylacetamide
deacetylase-like 1 (AADACL1), mRNA
[NM_020792]
XR_011345 0.029255124 2.6165082 up 1.450092 up 1.492756 down PREDICTED: Macaca mulatta similar to
otoancorin isoform 1 (LOC699600),
mRNA [XR_011345]
FN1 0.02028952 2.6025481 down 1.05622 down 1.051482 down Homo sapiens fibronectin 1 (FN1),
transcript variant 1, mRNA
[NM_212482]
SP7 3.05E-04 2.5985072 up 1.616763 up 1.088733 down Homo sapiens Sp7 transcription
factor (SP7), mRNA [NM_152860]
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ELMOD1 0.011425177 25.931845 down 1.737314 down 2.051013 up Homo sapiens ELMO/CED-12 domain
containing 1 (ELMOD1), mRNA
[NM_018712]
RBBP9 0.026729036 11.012514 down 1.47388 down 5.131376 down Homo sapiens retinoblastoma binding
protein 9 (RBBP9), mRNA [NM_006606]
MMP25 0.001325307 10.996225 down 2.384582 down 1.436251 down Homo sapiens matrix metallopeptidase
25 (MMP25), mRNA [NM_022468]
C5orf46 0.047762383 10.762607 down 1.234639 up 1.096919 up Homo sapiens similar to AVLV472
(MGC23985), mRNA [NM_206966]
GOLSYN 2.29E-05 6.13113 up 1.05566 up 1.458383 up Homo sapiens hypothetical protein
FLJ20366 (FLJ20366), mRNA
[NM_017786]
LCN15 0.005291665 5.3478875 up 1.891747 up 2.217465 up Homo sapiens MSFL2541 (UNQ2541),
mRNA [NM_203347]
CCDC146 0.030661521 5.281487 up 1.06658 up 1.360575 up Homo sapiens KIAA1505 protein
(KIAA1505), mRNA [NM_020879]
AK094929 0.001118242 5.262121 up 1.690864 up 1.110624 up Homo sapiens cDNA FLJ37610 fis,
clone BRCOC2011398. [AK094929]
SORCS3 0.00328917 5.0026994 up 2.266284 up 2.921157 up Homo sapiens sortilin-related VPS10
domain containing receptor 3
(SORCS3), mRNA [NM_014978]
COL4A4 0.01571377 4.897748 down 1.548386 down 1.059327 down Homo sapiens collagen, type IV, alpha
4 (COL4A4), mRNA [NM_000092]
IL1R2 0.004347455 4.777918 down 1.8715 down 1.690538 down Homo sapiens interleukin 1 receptor,
type II (IL1R2), transcript variant 1,
mRNA [NM_004633]
CD200R1 0.04967409 4.7169123 down 1.052303 up 1.319852 down Homo sapiens CD200 receptor 1
(CD200R1), transcript variant 1, mRNA
[NM_138806]
GTSF1 0.017040279 4.653995 up 3.663281 up 2.487166 up Homo sapiens family with sequence
similarity 112, member B (FAM112B),
mRNA [NM_144594]
SNAI1 0.005038617 4.582946 down 1.534132 down 1.847129 down Homo sapiens snail homolog 1
(Drosophila) (SNAI1), mRNA
[NM_005985]
USH1C 0.00505742 4.3276477 up 1.595945 up 1.465964 up Homo sapiens Usher syndrome 1C
(autosomal recessive, severe) (USH1C),
transcript variant 1, mRNA
[NM_005709]
ALLC 0.006709512 4.060955 up 1.861818 up 2.766094 up Homo sapiens allantoicase (ALLC),
transcript variant 1, mRNA
[NM_018436]
CXCL3 0.04903758 3.9091544 down 1.096309 down 1.172056 up Homo sapiens chemokine (C-X-C motif)
ligand 3 (CXCL3), mRNA [NM_002090]
XR_014204 0.029225934 3.8491352 down 3.167453 down 1.084816 up PREDICTED: Macaca mulatta
hypothetical protein LOC719546
(LOC719546), mRNA [XR_014204]
XR_011794 0.010519872 3.637105 up 3.785519 up 2.76764 up PREDICTED: Macaca mulatta similar to
poly(A)-specific ribonuclease (PARN)-like
domain containing 1 (LOC707835),
mRNA [XR_011794]
NMNAT2 0.045685206 3.6255727 up 2.521069 down 2.189285 up Homo sapiens nicotinamide nucleotide
adenylyltransferase 2 (NMNAT2),
transcript variant 1, mRNA
[NM_015039]
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Table 3 List of top 50 genes significantly differentially regulated in liver based on fold difference (t-test). (Continued)
SLC39A8 0.041505713 3.6139402 down 1.366996 down 1.390711 down Homo sapiens solute carrier family 39
(zinc transporter), member 8 (SLC39A8),
mRNA [NM_022154]
CA2 0.033340864 3.4830022 down 3.573662 down 1.194329 up Homo sapiens carbonic anhydrase II
(CA2), mRNA [NM_000067]
NTRK3 0.003890598 3.4711208 up 1.593136 up 1.043792 down Homo sapiens neurotrophic tyrosine
kinase, receptor, type 3 (NTRK3),
transcript variant 1, mRNA
[NM_001012338]
C17orf75 0.001362531 3.4477015 down 3.758336 down 1.443745 down Homo sapiens chromosome 17 open
reading frame 75 (C17orf75), mRNA
[NM_022344]
CXCL1 0.006956845 3.392382 down 1.063934 up 4.611126 down Homo sapiens chemokine (C-X-C motif)
ligand 1 (melanoma growth
stimulating activity, alpha) (CXCL1),
mRNA [NM_001511]
NM_198692 0.03194352 3.3605232 down 1.343767 up 1.654617 down Homo sapiens keratin associated
protein 10-11 (KRTAP10-11), mRNA.
[NM_198692]
SHANK2 0.023280138 3.3547363 up 1.255762 up 1.189415 down Homo sapiens SH3 and multiple
ankyrin repeat domains 2 (SHANK2),
transcript variant 1, mRNA
[NM_012309]
CCDC81 0.004982437 3.2717588 down 1.533572 down 4.912844 down Homo sapiens coiled-coil domain
containing 81 (CCDC81), mRNA
[NM_021827]
CCL11 0.008992519 3.1781478 down 4.050988 down 1.002582 up Homo sapiens chemokine (C-C motif)
ligand 11 (CCL11), mRNA [NM_002986]
CO647386 0.020776557 3.1651435 down 1.030158 down 1.631509 down ILLUMIGEN_MCQ_40418 Katze_MMPB2
Macaca mulatta cDNA clone
IBIUW:21432 5’ similar to Bases 185 to
778 highly similar to human CXCL2
(Hs.75765), mRNA sequence
[CO647386]
GPR98 0.024752488 3.1570897 down 1.10821 down 3.919889 down Homo sapiens G protein-coupled
receptor 98 (GPR98), transcript variant
1, mRNA [NM_032119]
TMEM59L 5.34E-04 3.137047 up 1.57364 up 1.407988 up Homo sapiens transmembrane protein
59-like (TMEM59L), mRNA [NM_012109]
UGT1A6 0.040070046 3.1353552 down 2.066639 down 1.399845 down Homo sapiens UDP
glucuronosyltransferase 1 family,
polypeptide A6 (UGT1A6), transcript
variant 1, mRNA [NM_001072]
KCNE2 7.02E-04 3.1135461 up 1.972823 up 1.170852 down Homo sapiens potassium voltage-gated
channel, Isk-related family, member 2
(KCNE2), mRNA [NM_172201]
XR_012376 0.022554293 3.0699794 down 1.9303 down 1.439485 down PREDICTED: Macaca mulatta
hypothetical protein LOC710335
(LOC710335), mRNA [XR_012376]
RXFP1 0.002097808 3.0400152 up 1.931833 up 1.276558 up Homo sapiens relaxin/insulin-like family
peptide receptor 1 (RXFP1), mRNA
[NM_021634]
ITGBL1 0.02861261 3.0041916 down 2.563332 down 1.243521 down Homo sapiens integrin, beta-like 1
(with EGF-like repeat domains) (ITGBL1),
mRNA [NM_004791]
PASK 0.03426426 2.995584 up 5.977056 up 19.17474 up Homo sapiens PAS domain containing
serine/threonine kinase (PASK), mRNA
[NM_015148]
DEFB1 0.004949556 2.9797235 down 1.065357 up 2.807533 down Homo sapiens defensin, beta 1 (DEFB1),
mRNA [NM_005218]
WDR8 0.004681234 2.9781044 down 5.68043 down 8.061375 down Homo sapiens WD repeat domain 8
(WDR8), mRNA [NM_017818]
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more than a 10 fold shift in expression levels. There are
important implications to this observation. Historically,
experimental and epidemiological focus has been on the
extremes of birth weight (either small for gestational age
or large for gestational age) and there has been little
focus within the normal birth weight range continuum.
What is evident from the present study is that relatively
small changes in the birth phenotype may be associated
with profound changes in molecular physiology. In turn
this also suggests the presence of highly evolved pro-
cesses by which the fetus can adjust its development in
response to subtle cues from mother [29].
The Cynomolgus, as in the human, has monotocous
pregnancies with haemochorial placentae; they have
omnivorous diets and monogastric digestion. They also
share with humans the same progressive history of the
metabolic syndrome [17]. We have identified alterations
in the levels and expression patterns of a number of
genes involved in different metabolic processes including
cellular lipid metabolism, cellular biosynthesis, cellular
macromolecule synthesis, cellular nitrogen metabolism,
cellular carbohydrate metabolism, cellular catabolism,
nucleotide and nucleic acid metabolism, biological adhe-
sion and development.Recently, transcriptional profiling
in rats subjected to gestational under nutrition was per-
formed in young adult male rats where 249 genes were
shown to be differentially expressed in the liver [28].
We compared the genes which are significantly altered
in our array with those identified in the rat array study
and have identified twelve similar or closely related
genes from those identified in the rat: Tribbles homolog
2 (Trib2); 3-hydroxyanthanillate dioxygenase (Haao),
transmembrane serine protease 6 (Tmmprss6); Thiore-
doxin domain containing10 (Txndc10); tralation initia-
tion factor 4A3 (Eifa3); Ribosomal protein L31 (Rpl31);
Danse 1-like 2 (Dnase1l2); Quinolate phosphoribosyl
transferase (Qprt); general transcription factor IIa 2
(Gtf2a3); General transcription factor II H 3 [28]. Only
four of these genes (Trib2, Trip10, EIF4A3 and Dna-
se1l2) were altered in the same direction in the livers of
LBW macaques as in the rat array. We have also com-
pared our observations with those identified from LBW
Table 3 List of top 50 genes significantly differentially regulated in liver based on fold difference (t-test). (Continued)
RIMS4 0.04112827 2.9677074 up 1.724443 up 1.024011 down Homo sapiens regulating synaptic
membrane exocytosis 4 (RIMS4), mRNA
[NM_182970]
PDGFRL 0.011396675 2.9371088 down 1.21306 down 1.55284 down Homo sapiens platelet-derived growth
factor receptor-like (PDGFRL), mRNA
[NM_006207]
TNRC4 0.005930619 2.9251838 up 1.208589 up 1.396738 up Homo sapiens trinucleotide repeat
containing 4 (TNRC4), mRNA
[NM_007185]
UGT2B11 0.02518766 2.9193914 down 1.09908 down 2.958316 down Homo sapiens UDP
glucuronosyltransferase 2 family,
polypeptide B11 (UGT2B11), mRNA
[NM_001073]
FLT3LG 0.029793594 2.8908129 up 1.037797 down 1.527226 up Homo sapiens fms-related tyrosine
kinase 3 ligand (FLT3LG), mRNA
[NM_001459]
IP6K3 0.03900314 2.8685477 up 1.471319 up 1.39455 down Homo sapiens inositol hexaphosphate
kinase 3 (IHPK3), mRNA [NM_054111]
ST6GALNAC1 0.03669531 2.8622296 down 1.408642 down 2.126189 down Homo sapiens ST6 (alpha-N-acetyl-
neuraminyl-2,3-beta-galactosyl-1,3)-N-
acetylgalactosaminide alpha-2,6-
sialyltransferase 1 (ST6GALNAC1), mRNA
[NM_018414]
EFNA4 0.007086268 2.843187 down 1.084758 up 2.766163 down Homo sapiens ephrin-A4 (EFNA4),
transcript variant 1, mRNA
[NM_005227]
MYST3 0.013409907 2.827006 up 3.302978 up 1.403819 up Homo sapiens MYST histone
acetyltransferase (monocytic leukemia)
3 (MYST3), mRNA [NM_006766]
XM_370715 0.001614059 2.7565975 up 1.561267 up 2.382949 up PREDICTED: Homo sapiens similar to
hypothetical protein MGC48915
(LOC387911), mRNA [XM_370715]
NM_031436 0.035783853 2.6903787 up 1.740635 up 1.698687 up Homo sapiens aldo-keto reductase
family 1, member C-like 2 (AKR1CL2),
mRNA. [NM_031436]
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ATP5F1 0.003504217 29.998667 down 1.850386 down 1.153583 down Homo sapiens ATP synthase, H+
transporting, mitochondrial F0 complex,
subunit B1 (ATP5F1), nuclear gene
encoding mitochondrial protein, mRNA
[NM_001688]




CNPY2 6.12E-05 24.275322 down 2.033511 down 1.345912 down Homo sapiens transmembrane protein
4 (TMEM4), mRNA [NM_014255]
IMMP1L 5.31E-04 21.21959 down 1.067236 down 1.052987 up Homo sapiens IMP1 inner
mitochondrial membrane peptidase-like
(S. cerevisiae) (IMMP1L), mRNA
[NM_144981]
GNL2 0.008845676 19.523186 down 1.389994 down 1.352022 up Homo sapiens guanine nucleotide
binding protein-like 2 (nucleolar)
(GNL2), mRNA [NM_013285]
HRSP12 0.010644738 19.35189 down 1.121147 up 1.013192 up Homo sapiens heat-responsive protein
12 (HRSP12), mRNA [NM_005836]
CN643639 2.57E-05 19.177528 down 1.710693 down 1.132373 up ILLUMIGEN_MCQ_8235 Katze_MMBR
Macaca mulatta cDNA clone IBIUW:3333
5’ similar to Bases 1 to 682 highly
similar to human Unigene Hs.513885,
mRNA sequence [CN643639]
PASK 0.03426426 19.17474 up 5.977056 up 2.995584 up Homo sapiens PAS domain containing
serine/threonine kinase (PASK), mRNA
[NM_015148]
NDUFC1 1.93E-04 18.786453 down 1.418954 down 1.095977 up Homo sapiens NADH dehydrogenase
(ubiquinone) 1, subcomplex unknown,
1, 6 kDa (NDUFC1), mRNA [NM_002494]
BNIP3L 3.67E-05 18.46857 down 2.523903 down 1.123252 down Homo sapiens BCL2/adenovirus E1B 19
kDa interacting protein 3-like (BNIP3L),
mRNA [NM_004331]
GALE 0.004030123 18.304993 down 1.591229 up 1.378757 down Homo sapiens UDP-galactose-4-
epimerase (GALE), transcript variant 1,
mRNA [NM_000403]
XM_371837 2.06E-06 18.251152 down 1.76245 down 1.15429 down PREDICTED: Homo sapiens similar to
oxidoreductase UCPA (LOC389416),
mRNA [XM_371837]
OSTCL 9.90E-05 17.57389 down 1.173702 down 1.075778 down Homo sapiens similar to RIKEN cDNA
2310008M10 (LOC202459), mRNA
[NM_145303]
WDR75 7.83E-05 17.02899 down 2.353145 down 1.037028 down Homo sapiens WD repeat domain 75
(WDR75), mRNA [NM_032168]
SMPDL3A 1.25E-05 16.127317 down 1.290077 down 1.780315 down Homo sapiens sphingomyelin
phosphodiesterase, acid-like 3A
(SMPDL3A), mRNA [NM_006714]
LIN7C 6.29E-04 15.929515 down 1.429568 down 1.006664 down Homo sapiens lin-7 homolog C (C.
elegans) (LIN7C), mRNA [NM_018362]
COX7B 8.03E-06 15.9135065 down 1.283232 down 1.138854 up Homo sapiens cytochrome c oxidase
subunit VIIb (COX7B), nuclear gene
encoding mitochondrial protein, mRNA
[NM_001866]
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Table 4 Top 50 genes significantly differentially regulated in cord based on fold difference (t-test). (Continued)
MRPL1 1.35E-06 15.901582 down 1.776047 down 1.05264 up Homo sapiens mitochondrial ribosomal
protein L1 (MRPL1), nuclear gene
encoding mitochondrial protein, mRNA
[NM_020236]
NPM3 3.58E-04 15.357531 down 1.39378 down 1.314134 up Homo sapiens nucleophosmin/
nucleoplasmin, 3 (NPM3), mRNA
[NM_006993]
RNF126 4.43E-04 15.14725 down 1.165075 down 1.084156 down Homo sapiens ring finger protein 126
(RNF126), transcript variant 2, mRNA
[NM_194460]
ATG4C 1.86E-06 14.422242 down 1.01449 down 1.571663 down Homo sapiens ATG4 autophagy related
4 homolog C (S. cerevisiae) (ATG4C),
transcript variant 7, mRNA [NM_032852]
ACMSD 2.00E-04 14.3137 down 1.121731 up 1.098467 down Homo sapiens aminocarboxymuconate
semialdehyde decarboxylase (ACMSD),
mRNA [NM_138326]
WASF3 0.0026955 14.211387 down 1.134297 down 1.574282 up Homo sapiens WAS protein family,
member 3 (WASF3), mRNA
[NM_006646]
F13B 1.26E-05 13.94526 down 1.052562 down 1.02993 down Homo sapiens coagulation factor XIII, B
polypeptide (F13B), mRNA [NM_001994]
HNRNPA1L2 0.007305239 13.879195 down 1.288451 up 1.062584 down Homo sapiens heterogeneous nuclear
ribonucleoprotein A1-like (LOC144983),
transcript variant 1, mRNA
[NM_001011724]
XR_011737 0.001940294 13.592515 down 1.736661 down 1.168041 up PREDICTED: Macaca mulatta similar to
transcription factor B2, mitochondrial
(LOC710669), mRNA [XR_011737]
CP 1.42E-04 13.285389 down 1.122256 down 1.274657 down Homo sapiens ceruloplasmin
(ferroxidase) (CP), mRNA [NM_000096]
TOLLIP 1.59E-04 12.683504 down 1.156986 down 1.00844 down Homo sapiens toll interacting protein
(TOLLIP), mRNA [NM_019009]
DARS 3.99E-05 12.632657 down 3.152794 down 1.10567 down Homo sapiens aspartyl-tRNA synthetase
(DARS), mRNA [NM_001349]
CKLF 4.24E-04 12.476327 down 1.130294 down 1.064736 down Homo sapiens chemokine-like factor
(CKLF), transcript variant 1, mRNA
[NM_016951]
STT3B 1.13E-04 12.457355 down 2.027118 down 1.030927 down Homo sapiens STT3, subunit of the
oligosaccharyltransferase complex,
homolog B (S. cerevisiae) (STT3B),
mRNA [NM_178862]
TXNDC11 4.40E-05 12.377014 down 1.525444 down 1.011564 down Homo sapiens thioredoxin domain
containing 11 (TXNDC11), mRNA
[NM_015914]
CR603105 9.80E-04 12.209639 down 1.284419 down 1.155491 down full-length cDNA clone CS0DF006YN22
of Fetal brain of Homo sapiens (human)
[CR603105]
XR_010672 5.09E-05 11.634537 down 1.602301 down 1.059423 up PREDICTED: Macaca mulatta similar to
Molybdenum cofactor synthesis protein
2 large subunit (Molybdopterin
synthase large subunit) (MPT synthase
large subunit) (MOCS2B) (MOCO1-B)
(LOC703049), mRNA [XR_010672]
GDE1 0.03917646 11.536806 down 1.190901 up 1.20255 up Homo sapiens membrane interacting
protein of RGS16 (MIR16), mRNA
[NM_016641]
CFHR2 2.07E-04 11.37657 down 1.208862 down 1.032327 down Homo sapiens complement factor H-
related 2 (CFHR2), mRNA [NM_005666]
RPL30 0.03067462 11.374878 down 1.173423 up 1.096937 up Homo sapiens ribosomal protein L30
(RPL30), mRNA [NM_000989]
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term placentas by McCarthy and colleagues [30] and
found similarities in expression changes in the genes
Procollagen-lysine, 2-oxoglutarate 5-dioygense
(PLOD2); Soluble interleukin-1 receptor accessory pro-
tein (IL1RAP); Solute carrier family 2 (facilitated glu-
cose transporter) member3 (SLC2A3); Myosin V1
(MYH6); Ribosomal protein S6(RPS6) and Latexin
(LXN). The Tribbles homolog 2 (Trib2) is also
increased in the LBW infants and suggests another
possible way in way insulin/IGF-1 signalling might be
impaired during development. Tribbles belongs to a
family of kinase-like proteins and are reported to be
negative regulators of Akt, the principle target of insu-
lin signaling [31,32].
Studies using animal models such as rodents to under-
stand the developmental origins of metabolic diseases
have shown that epigenetic changes in genes correlates
with expression changes including metabolic enzymes
such as PEPCK, transcriptional factors such as PPARa
which regulate fat metabolism and factors associated
with insulin action (e.g. PI3 kinase, PKC-ζ), the key reg-
ulatory genes which are responsible for bringing these
changes are not known [15,33]. One aim in our study
was to identify whether there were shifts within the
expression of key early regulators and from the array we
have identified one such key regulatory gene the PAS
Kinase (PASK), an evolutionarily conserved PAS domain
containing serine/threonine kinase whose expression is
Table 4 Top 50 genes significantly differentially regulated in cord based on fold difference (t-test). (Continued)
XM_495885 0.002429009 11.322625 down 1.165255 down 1.156577 down PREDICTED: Homo sapiens similar to
ribosomal protein S12 (LOC440055),
mRNA [XM_495885]
NDUFB1 2.13E-04 11.293429 down 1.404433 down 1.277028 up Homo sapiens NADH dehydrogenase
(ubiquinone) 1 beta subcomplex, 1, 7
kDa (NDUFB1), mRNA [NM_004545]
NM_032807 2.89E-04 11.240869 down 1.075345 down 1.014724 down Homo sapiens F-box protein, helicase,




1.34E-05 11.216295 down 1.714551 down 1.080183 down Homo sapiens chondroitin sulfate
GalNAcT-2 (GALNACT-2), mRNA
[NM_018590]
NM_022333 0.002598488 10.94874 down 1.130622 up 1.014866 down Homo sapiens TIA1 cytotoxic granule-
associated RNA binding protein-like 1
(TIAL1), ranscript variant 2, mRNA
[NM_022333]
NM_032807 0.001172931 10.342792 down 1.522541 down 1.139832 down Homo sapiens F-box protein, helicase,
18 (FBXO18), transcript variant 1, mRNA.
[NM_032807]
AAMP 2.62E-05 10.171815 down 1.560637 down 1.085371 down Homo sapiens angio-associated,
migratory cell protein (AAMP), mRNA
[NM_001087]
ESF1 1.02E-07 9.745275 down 1.620818 down 1.008674 down Homo sapiens ESF1, nucleolar pre-rRNA
processing protein, homolog (S.
cerevisiae) (ESF1), mRNA [NM_016649]
DOCK7 0.01799708 9.74066 down 1.174452 up 1.171709 up Homo sapiens dedicator of cytokinesis
7 (DOCK7), mRNA [NM_033407]
DDX3Y 4.78E-06 9.687978 down 1.356089 down 1.134329 down Homo sapiens DEAD (Asp-Glu-Ala-Asp)
box polypeptide 3, Y-linked (DDX3Y),
mRNA [NM_004660]
XIAP 3.65E-05 9.587557 down 1.882389 down 1.280735 up Homo sapiens baculoviral IAP repeat-
containing 4 (BIRC4), mRNA
[NM_001167]
TRPC4AP 9.51E-05 9.4549885 down 1.340843 down 1.07043 up Homo sapiens transient receptor
potential cation channel, subfamily C,
member 4 associated protein
(TRPC4AP), transcript variant 1, mRNA
[NM_015638]
ADK 1.63E-04 9.386349 down 5.639505 down 1.368648 down Homo sapiens adenosine kinase (ADK),




3.92E-04 9.258961 down 1.016391 up 1.220083 down Homo sapiens chromosome 1 open
reading frame 139 (C1orf139), transcript
variant 2, mRNA. [NM_001002292]
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altered as a result of adverse early developmental condi-
tions. PAS domains are evolutionarily conserved and
appear from archaea, bacteria to eukaryotes and are pre-
sent in many signaling proteins where they act as signal
sensor domain [34]. The PASK gene, whereby expres-
sion was up regulated in the LBW animals, has been
shown to be a metabolic sensor based on mice knock-
out studies; mice lacking PASK are resistant to high-fat
induced obesity, hepatic steatosis and are resistant to
insulin [35].
Conclusions
In summary, this paper has identified significant varia-
tion in gene expression in multiple tissues in primate
newborns of different growth trajectories but within the
normative range of birth size. Further detailed analyses
Table 5 Gene ontology classification to group genes using Genespring ver10 (Agilent Tech, Santa Clara) of similar
functional families.













Cellular lipid metabolic process 15 6 4 4 13 11
Cellular biosynthesis process 8 14 6 4 16 40
Cellular macromolecule synthesis 21 32 19 14 45 63
Cellular nitrogen metabolic process 4 1 4 0 7 1
Cellular carbohydrate metabolic process 2 0 0 0 2 1
Cellular catabolic process 1 2 0 0 2 1
Nucleobase, Nucleoside, nucleotide and nucleic acid
metabolic process
19 17 15 4 66 43
Other cellular metabolic process 3 2 1 3 3 15
Other metabolic process 5 7 5 2 9 11
Transport 30 17 21 14 39 26
Regulation of molecular functions 4 2 1 1 12 8
Biological adhesion 6 8 4 5 8 10
Developmental process 19 11 7 4 20 16
Other biological process 38 38 25 19 65 59
Table 6 Verification of seven genes from the microarray using Real-time RT-PCR analysis in skeletal muscle.








XM_116936 0.017913306 10.054285 Up regulated
PREDICTED: Homo sapiens similar to RIKEN cDNA
4832428D23 gene
4.780893
PASK: 0.03426426 5.977056 Up regulated
Homo sapiens PAS domain containing serine/threonine
kinase
14.55481
ADK: 1.63E-04 -5.639505 Down regulated




Homo sapiens ELMO/CED-12 domain containing 1. 0.011425177 -1.7373136 Down regulated -1.71015
SIX1:
Homo sapiens sine oculis homeobox homolog 1
(Drosophila).




Homo sapiens retinoblastoma-like 1 (p107), (transcript
variant 1)
0.011705314 1.5320477 Up regulated 3.023726
SLC12A9:
Homo sapiens solute carrier family 12 (potassium/chloride
transporters), member 9.
1.31E-05 1.3670695 Up regulated 1.694303
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may improve our understanding of how alterations in
such genes due to adverse early life environment predis-
poses towards metabolic syndrome. These data give
strength to the hypothesis that developmental plasticity
operating within the normative range of birth weights
can influence metabolic and other physiological systems
in a way that might have later health consequences. It
emphasizes that the concept of developmental program-
ming need not involve pathological changes in growth
trajectories to have molecular and presumably functional
consequences.
Additional material
Additional file 1: Genes which were differentially regulated
between the ABW and LBW groups classified based on GO terms.
Genes with a ≥ 1.5 fold change at least in one tissue with a p value of ≥
0.5 identified from the array with the GO terms
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